Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like <b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017 FDA Gives Go-Ahead for Tetra's Phase II Trial March 15, 2018 Top Trends Impacting Biopharma Innovation Strategy in 2018 January 23, 2018
<b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017
